SANOFI-AVENTIS U.S. LLC: Biologic license for SARCLISA ESCENA
SANOFI-AVENTIS U.S. LLC: Biologic license for SARCLISA ESCENA. Dated 118 days ago, it serves as a historical benchmark. Score 55/100. As of 2026-11-04, from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).
Data as of · Compiled by Zalwin from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
Free preview: all 7 published fields of this record are shown below. Locked: 499 related FdaApprovalPulse records and the 4-column CSV export.
| Field | Value |
|---|---|
| Sponsor | SANOFI-AVENTIS U.S. LLC |
| Product | SARCLISA ESCENA |
| Generic / ingredient | ISATUXIMAB-IRFC |
| Approval | Biologic license (BLA) |
| Application | BLA761445 |
| Decided | 2026-07-09 |
| Panel / class | VIAL, SINGLE-DOSE |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch SANOFI-AVENTIS U.S. LLC
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock SANOFI-AVENTIS U.S + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Product · Approval · Decided · official source URL
- Source agency: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
- Record date: 2026-07-09
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top FdaApprovalPulse records: Instylla, Inc. · Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) · Cerenovus, Inc. · Advanced Medical Solutions Limited · Lenstec, Inc. · Browse all by state and category →
LIVE PUBLIC DATA Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) · Last refreshed: Wed, 04 Nov 2026 06:06:18 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
55 / 100 Score
- A new product launch.
What is the FdaApprovalPulse record for SANOFI-AVENTIS U.S. LLC?
The FDA approved SARCLISA ESCENA (BLA761445) for SANOFI-AVENTIS U.S. LLC on 2026-07-09: biologic license (BLA).
How does SANOFI-AVENTIS U.S. LLC compare to other FdaApprovalPulse records?
It is 118 days old; check the official source for later updates before acting.
SANOFI-AVENTIS U.S. LLC vs. top 3 peers
| Organization | Record date |
|---|---|
| SANOFI-AVENTIS U.S. LLC | 2026-07-09 |
| AMGEN INC | 2026-10-22 |
| SANDOZ INC | 2026-10-22 |
| TEVA PHARMACEUTICALS, INC. | 2026-09-25 |
Related records
FdaApprovalPulse: Biologic license (BLA)
How to monitor SANOFI-AVENTIS U.S. LLC and peer biologic license (bla) records
Get new FdaApprovalPulse records like SANOFI-AVENTIS U.S. LLC by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new approvals in your categories
FdaApprovalPulse emails new device and drug approvals matching your approval types.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.